Christopher Willett
Author
Alternate names Christopher W. Willett, C. Willett, Christopher Willett
Institution Duke Medical Center
Past institutions Duke University, Duke Medical Center, Cambridge University Press, Ng Teng Fong General Hospital, National Rehabilitation Center +5 more
H-index: 13
I10-index: 17
Works count: 48
Citations count: 731
Impact of Body Mass Index on Outcomes and Treatment-Related Toxicity in Patients With Stage II and III Rectal Cancer: Findings From Intergroup Trial 0114
2004 · Jeffrey A. Meyerhardt, Joel E. Tepper, et al. · Journal of Clinical Oncology
Intergroup RTOG 98–11: A phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal
2006 · Jaffer A. Ajani, Kathryn Winter, et al. · Journal of Clinical Oncology
RTOG 0529: A Phase II Evaluation of Dose-painted IMRT in Combination with 5-Fluorouracil and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal
2009 · Lisa A. Kachnic, Kathryn Winter, et al. · International Journal of Radiation Oncology*Biology*Physics